Back to Search
Start Over
Ferroptosis as a novel form of regulated cell death: Implications in the pathogenesis, oncometabolism and treatment of human cancer
- Source :
- Genes and Diseases, Vol 9, Iss 2, Pp 347-357 (2022)
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
-
Abstract
- The treatment of cancer mainly involves surgical excision supplemented by radiotherapy and chemotherapy. Chemotherapy drugs act by interfering with tumor growth and inducing the death of cancer cells. Anti-tumor drugs were developed to induce apoptosis, but some patient’s show apoptosis escape and chemotherapy resistance. Therefore, other forms of cell death that can overcome the resistance of tumor cells are important in the context of cancer treatment. Ferroptosis is a newly discovered iron-dependent, non-apoptotic type of cell death that is highly negatively correlated with cancer development. Ferroptosis is mainly caused by the abnormal increase in iron-dependent lipid reactive oxygen species and the imbalance of redox homeostasis. This review summarizes the progression and regulatory mechanism of ferroptosis in cancer and discusses its possible clinical applications in cancer diagnosis and treatment.
- Subjects :
- 0301 basic medicine
Medicine (General)
Programmed cell death
Cancer therapy
medicine.medical_treatment
Lipid peroxidation
Context (language use)
Pathogenesis
QH426-470
Biochemistry
03 medical and health sciences
R5-920
0302 clinical medicine
Genetics
medicine
Ferroptosis
Molecular Biology
Genetics (clinical)
Cancer
chemistry.chemical_classification
Reactive oxygen species
Chemotherapy
business.industry
Cell Biology
medicine.disease
Clinical application
Radiation therapy
030104 developmental biology
chemistry
Apoptosis
030220 oncology & carcinogenesis
Cancer cell
Cancer research
business
Subjects
Details
- ISSN :
- 23523042
- Volume :
- 9
- Database :
- OpenAIRE
- Journal :
- Genes & Diseases
- Accession number :
- edsair.doi.dedup.....99e72ca2b1d66a524a3c0350ff29d071
- Full Text :
- https://doi.org/10.1016/j.gendis.2020.11.019